TrialBMC cancer2008
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.
John M Pendleton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it